|
"kao j h"的相关文件
显示项目 1151-1160 / 1534 (共154页)
<< < 111 112 113 114 115 116 117 118 119 120 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-02-10T08:59:14Z |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Lin Y.-H.;Hwang R.-M.;Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Kao J.-H.;Lee H.-S.;Liang P.-C.;Wei S.-Y.;Shih T.T.F.; Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F.; HSUAN-SHU LEE |
| 臺大學術典藏 |
2020-01-22T04:47:48Z |
High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments
|
Nien H.-C.;Hsu S.-J.;Su T.-H.;Yang P.-J.;Sheu J.-C.;Wang J.-T.;Lu-Ping Chow;Chen C.-L.;Kao J.-H.;Yang W.-S.; Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; LU-PING CHOW; Chen C.-L.; Kao J.-H.; Yang W.-S. |
| 臺大學術典藏 |
2020 |
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|
CHEN-HUA LIU; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Lin C.-Y.; Hung C.-H.; Huang Y.-H.; Huang C.-F.; Hu T.-H.; Chen P.-J.; Dai C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2020 |
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
|
Liu W.-D.; Liu W.-D.;Chang S.-Y.;Lan T.-Y.;Lin Y.-C.;Kao J.-H.;Liao C.-H.;Tsai M.-J.;Kuo P.-H.;Huang Y.-S.;Jann-Tay Wang;Sheng W.-H.;Hsieh S.-C.;Chiang B.-L.;Chen Y.-C.;Chang S.-C.; Chen Y.-C.; Chang S.-C.; Chang S.-Y.; Lan T.-Y.; Lin Y.-C.; Kao J.-H.; Liao C.-H.; Tsai M.-J.; Kuo P.-H.; Huang Y.-S.; JANN-TAY WANG; Sheng W.-H.; Hsieh S.-C.; Chiang B.-L. |
| 臺大學術典藏 |
2020 |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Liu C.-J.; Kao J.-H.; Chen Y.-W.; Chen P.-J.; Yang H.-C.; Su T.-H.; CHEN-HUA LIU; Hong C.-M. |
| 國立成功大學 |
2020 |
Systematic review: chronic viral hepatitis and metabolic derangement
|
Wang, C.-C.;Cheng, P.-N.;Kao, J.-H. |
| 國立成功大學 |
2020 |
Extrahepatic Malignancy among Patients with Chronic Hepatitis C after Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang, C.-F.;Lai, H.-C.;Chen, Chen C.-Y.;Tseng, K.-C.;Kuo, H.-T.;Hung, C.-H.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Tsai, P.-C.;Peng, C.-Y.;Yu, M.-L. |
| 國立成功大學 |
2020 |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu, W.-F.;Chen, Chen C.-Y.;Tseng, K.-C.;Lai, H.-C.;Kuo, H.-T.;Hung, C.-H.;Tung, S.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Lin, C.-Y.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Tsai, P.-C.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Yu, M.-L.;Peng, C.-Y. |
| 國立成功大學 |
2020 |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai, P.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Hung, C.-H.;Tseng, K.-C.;Lai, H.-C.;Peng, C.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Tai, C.-M.;Lin, C.-W.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, C.-F.;Hsieh, M.-H.;Huang, J.-F.;Dai, C.-Y.;Chung, W.-L.;Ke, C.-L.K.;Yu, M.-L.;Group, T-COACH Study |
| 國立成功大學 |
2020 |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistan
|
Huang, C.-F.;Hung, C.-H.;Cheng, P.-N.;Bair, M.-J.;Huang, Y.-H.;Kao, J.-H.;Hsu, S.-J.;Lee, P.-L.;Chen, J.-J.;Chien, R.-N.;Peng, C.-Y.;Lin, C.-Y.;Hsieh, T.-Y.;Cheng, Cheng C.-H.;Dai, C.-Y.;Huang, J.-F.;Chuang, W.-L.;Yu, M.-L. |
显示项目 1151-1160 / 1534 (共154页)
<< < 111 112 113 114 115 116 117 118 119 120 > >>
每页显示[10|25|50]项目
|
